Author:
Wilson Anna,Carswell Claire,McKeaveney Clare,Atkinson Karen,Burton Stephanie,McVeigh Clare,Graham-Wisener Lisa,Jääskeläinen Erika,Johnston William,O’Rourke Daniel,Reid Joanne,Rej Soham,Walsh Ian,Noble Helen
Abstract
Abstract
Background
Individuals with chronic kidney disease experience difficult physical and psychological symptoms, that impact quality of life, and are at increased risk of anxiety and depression. Access to specialist psychological support is limited. This study aimed to support a new service development project, in collaboration with Kidney Care UK, to implement the Compassionate Mindful Resilience (CMR) programme, developed by MindfulnessUK, which provides accessible mindfulness techniques and practices to enhance compassion and resilience, and explore its feasibility for people living with stage 4 or 5 kidney disease and transplant.
Methods
A multi-method feasibility design was utilised. Participants over 18 years, from the UK, with stage 4 or 5 kidney disease or post-transplant, and who were not currently undergoing psychotherapy, were recruited to the four-week CMR programme. Data was collected at baseline, post-intervention and three-months post to measure anxiety, depression, self-compassion, mental wellbeing, resilience, and mindfulness. The acceptability of the intervention for a kidney disease population was explored through qualitative interviews with participants, and the Mindfulness Teacher.
Results
In total, 75 participants were recruited to the study, with 65 completing the CMR programme. The majority were female (66.2%) and post-transplant (63.1%). Analysis of completed outcome measures at baseline and post-intervention timepoints (n = 61), and three-months post intervention (n = 45) revealed significant improvements in participant’s levels of anxiety (p < .001) and depression (p < .001), self-compassion (p = .005), mental wellbeing (p < .001), resilience (p.001), and mindfulness (p < .001).
Thematic analysis of interviews with participants (n = 19) and Mindfulness Teacher (n = 1) generated three themes (and nine-subthemes); experiences of the CMR programme that facilitated subjective benefit, participants lived and shared experiences, and practicalities of programme participation. All participants interviewed reported that they found programme participation to be beneficial.
Conclusion
The findings suggest that the CMR programme has the potential to improve psychological outcomes among people with chronic kidney disease. Future randomized controlled trials are required to further test its effectiveness.
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Kidney Care UK and National Psychosocial Working Group. Psychosocial Health – A Manifesto for Action 2022. Available from: https://www.kidneycareuk.org/about-kidney-health/living-kidney-disease/mental-health/manifesto/. Accessed 01 October 2021.
2. Donahue S, Quinn DK, Cukor D, Kimmel PL. Anxiety presentations and treatments in populations with kidney disease. Semin Nephrol. 2021;41(6):516–25.
3. Tsai Y-C, Chiu Y-W, Hung C-C, Hwang S-J, Tsai J-C, Wang S-L, et al. Association of symptoms of depression with progression of CKD. Am J Kidney Dis. 2012;60(1):54–61.
4. Dew MA, Rosenberger EM, Myaskovsky L, Dimartini AF, Devito Dabbs AJ, Posluszny DM, et al. Depression and anxiety as risk factors for morbidity and mortality after organ transplantation. Transplantation. 2015;100(5):988–1003.
5. Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14(1):82–99.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献